NCT02705326View on ClinicalTrials.gov

Evaluating the Efficacy of Opti-Speech for Speech Treatment

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Articulation DisorderDysarthriaPrelingual Deafness
Interventions
DEVICE

Opti-Speech

Uses visual feedback of the tongue's motion to guide speech sound production

Trial Locations (2)

44106

The Cleveland Hearing and Speech Center, Cleveland

75080

Callier Center for Communication Disorders at UT Dallas, Richardson

All Listed Sponsors
collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

collaborator

Callier Center for Communication Disorders

UNKNOWN

collaborator

Cleveland Hearing and Speech Center

UNKNOWN

collaborator

Case Western Reserve University

OTHER

lead

Vulintus, Inc.

INDUSTRY

NCT02705326 - Evaluating the Efficacy of Opti-Speech for Speech Treatment | Biotech Hunter | Biotech Hunter